ALLIANCEBERNSTEIN L.P. - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 108 filers reported holding STOKE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.5%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$548,911
+8.9%
40,630
+8.8%
0.00%
Q1 2024$504,090
+156.7%
37,3400.0%0.00%
Q4 2023$196,408
+20.6%
37,340
-9.6%
0.00%
Q3 2023$162,801
-62.9%
41,3200.0%0.00%
Q2 2023$439,232
+51.5%
41,320
+18.7%
0.00%
Q1 2023$289,884
+3.3%
34,800
+14.5%
0.00%
Q4 2022$280,592
-20.5%
30,400
+10.5%
0.00%
Q3 2022$353,000
+12.8%
27,500
+16.0%
0.00%
Q2 2022$313,000
-24.9%
23,700
+19.7%
0.00%
Q1 2022$417,000
-12.2%
19,8000.0%0.00%
Q4 2021$475,000
+0.4%
19,800
+6.5%
0.00%
Q3 2021$473,000
-29.0%
18,600
-6.1%
0.00%
Q2 2021$666,000
-5.3%
19,800
+9.4%
0.00%
Q1 2021$703,000
-34.8%
18,100
+4.0%
0.00%
-100.0%
Q4 2020$1,078,000
+55.6%
17,400
-15.9%
0.00%
Q3 2020$693,000
+32.8%
20,700
-5.5%
0.00%
Q2 2020$522,000
+31.8%
21,900
+26.6%
0.00%
Q1 2020$396,00017,3000.00%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 16,786,713$475,340,00079.82%
RTW INVESTMENTS, LP 3,544,248$100,373,0003.79%
Cormorant Asset Management, LP 1,788,643$50,654,0002.02%
RA Capital Management 1,119,963$31,717,0000.96%
Redmile Group, LLC 1,020,778$28,908,0000.69%
SPHERA FUNDS MANAGEMENT LTD. 256,380$7,261,0000.60%
GILDER GAGNON HOWE & CO LLC 1,826,890$51,738,0000.54%
Perceptive Advisors 671,978$19,030,0000.38%
Casdin Capital, LLC 130,000$3,682,0000.34%
Granite Point Capital Management, L.P. 13,200$374,0000.06%
View complete list of STOKE THERAPEUTICS INC shareholders